Logo

Dishman Carbo Share Price

NSE: DCAL
|
Pharmaceuticals
₹ 196.54
+₹8.79 (4.68%)
1D
Last updated 03 Jul, 2026, 15:58 IST

Dishman Carbo Share Price Today

As of 5 Jul 2026, Dishman Carbo share price is ₹196.54. The stock opened at ₹188.70, compared to its previous close of ₹187.75. During today's trading session, Dishman Carbo share price moved in the range of ₹187.80 to ₹201.90, with an average price of ₹194.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹128.50 and a high of ₹321.95. On the performance front, Dishman Carbo share price has declined by 22.86% over the last six months and is down 23.21% on a year-on-year basis.


₹187.80
4.68% up today
₹201.90
1D LOW
1D HIGH

Dishman Carbo Returns Calculator

Open
₹188.70
High
₹201.90
Low
₹187.80
Prev. close
₹187.75

Circuit
L
H
₹157.24
₹235.84
52-week
L
H
₹128.50
₹321.95

Dishman Carbo Shareholder Returns

Dishman Carbo Share Price History

Mkt Cap Cr
2,947.52

P/E
30.23

P/B
0.44

ROE
1.46%

D/E
0.16

ROCE
2.66%

Div. Yield
0.00%

EPS(TTM)
-2.45
Turnover
0.05

EV/EBITDA
7.84

Net Margin
0.00%

Op. Margin
0.00%

ROA
0.82%

Quick Ratio
0.00

Curr. Ratio
1.92
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Dishman Carbogen has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Dishman Carbogen appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Dishman Carbogen revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Dishman Carbo Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,711.50₹2,615.77₹2,412.92₹2,140.69
Other Income₹21.68₹28.21₹27.77₹43.42
Total Revenue₹2,733.18₹2,643.98₹2,440.69₹2,184.11
Total Expenses₹2,695.76₹2,760.10₹2,447.13₹2,173.72
Profit Before Tax₹19.31-₹122.26-₹54.59-₹4.25
Tax₹16.07₹31.19-₹24.79-₹22.26
Profit After Tax₹3.24-₹153.45-₹29.80₹18.01
EPS - Basic₹0.21-₹9.79-₹1.90₹1.15
EPS - Diluted₹0.21-₹9.79-₹1.90₹1.15

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹19.31-₹122.26-₹54.59-₹4.25
Income before WC changes₹486.14₹254.57₹337.87₹321.09
Change in Assets-₹208.14₹55.74-₹245.81-₹145.62
Change in Liabilities₹127.55₹88.09₹208.08₹235.71
Change in WC-₹80.59₹143.83-₹37.73₹90.09
Cash flow from Operations₹375.23₹379.43₹265.96₹354.85
Cash flow from Investing-₹192.21-₹229.52-₹494.08-₹618.53
Cash flow from Financing-₹102.09-₹22.15₹249.67₹130.38
Total Cash Flow₹80.93₹127.76₹21.55-₹133.30
Cash (Start of the year)₹264.09₹131.79₹110.24₹243.54
Cash (End of the year)₹341.07₹264.09₹131.79₹110.24

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹7,798.73₹7,653.22₹7,535.14₹6,798.73
Current Assets₹2,200.42₹1,928.19₹1,918.36₹1,838.72
Total Assets₹9,999.15₹9,581.41₹9,453.50₹8,637.45
Current Liabilities₹1,924.79₹2,554.72₹1,798.39₹1,419.79
Net Current Asset₹275.63-₹626.53₹119.97₹418.93
Non-Current Liabilities₹2,242.84₹1,399.19₹1,845.44₹1,668.72
Equity Capital₹5,831.52₹5,627.50₹5,809.67₹5,548.94
Total Equity & Liabilities₹9,999.15₹9,581.41₹9,453.50₹8,637.45

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹399.84₹327.35₹402.55₹306.61
Other Income₹32.98₹63.05₹52.16₹60.39
Total Revenue₹432.82₹390.40₹454.71₹367.00
Total Expenses₹463.65₹490.35₹548.91₹444.40
Profit Before Tax-₹30.83-₹103.00-₹96.20-₹83.31
Tax-₹20.96-₹26.59-₹37.33-₹52.84
Profit After Tax-₹9.87-₹76.41-₹58.87-₹30.47
EPS - Basic-₹0.63-₹4.87-₹3.75-₹2.01
EPS - Diluted-₹0.63-₹4.87-₹3.75-₹2.01

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹30.83-₹103.00-₹96.20-₹84.39
Income before WC changes₹64.84₹13.86₹4.76₹32.93
Change in Assets₹42.99-₹12.06-₹72.63₹14.00
Change in Liabilities-₹49.75₹23.59₹18.52₹186.55
Change in WC-₹6.76₹11.53-₹54.11₹200.55
Cash flow from Operations₹55.81₹24.17-₹52.90₹227.35
Cash flow from Investing-₹79.64₹96.57₹40.71-₹172.67
Cash flow from Financing₹87.51-₹130.76₹1.38-₹46.16
Total Cash Flow₹63.68-₹10.02-₹10.81₹8.52
Cash (Start of the year)₹4.05₹14.07₹24.88₹16.36
Cash (End of the year)₹67.73₹4.05₹14.07₹24.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹4,447.37₹4,489.44₹4,531.43₹4,448.52
Current Assets₹674.98₹587.22₹649.61₹765.79
Total Assets₹5,122.35₹5,076.66₹5,181.04₹5,214.31
Current Liabilities₹652.10₹618.73₹641.60₹551.19
Net Current Asset₹22.88-₹31.51₹8.01₹214.60
Non-Current Liabilities₹439.77₹405.35₹425.13₹431.34
Equity Capital₹4,030.48₹4,052.58₹4,114.31₹4,231.78
Total Equity & Liabilities₹5,122.35₹5,076.66₹5,181.04₹5,214.31
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
196.54
700
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 700
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
63.06
Neutral

ATR (14)
7.85
Neutral

STOCH(9,6)
84.32
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
23.38
Bearish

UO(9)
50.79
Neutral

ROC(12)
11.58
Bullish

WillR(14)
-15.47
Bearish
Period
Simple value
Exponential vaue

5D
180.84
184.42

10D
176.53
180.33

20D
178.22
180.23

50D
184.36
181.66

100D
178.31
189.34

About Dishman Carbo

Dishman Carbo logo
ISIN
INE385W01011
Sector Market Cap
₹ 2,947.52 Cr

Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.

Dishman Carbo Financial Highlights

  • Revenue: Dishman Carbo reported revenue of ₹2,987.84 crore in FY26 vs ₹2,733.18 crore in FY25. It showed an increase of 9.32% on a yearly basis.
  • Operating Profit: Dishman Carbo reported an operating profit of ₹104.90 crore in FY26 vs ₹19.31 crore in FY25. It showed an increase of 443.24% on a year-on-year basis.
  • Net Profit: Dishman Carbo reported a net profit of ₹97.45 crore in FY26 vs ₹3.24 crore in FY25. It showed an increase of 2,907.72% on a yearly basis.

Dishman Carbo Quarterly Result Highlights

  • Dishman Carbo reported revenue of ₹867.82 crore in Mar 2026, compared with ₹726.46 crore in Dec 2025, representing an increase of 19.46% on a quarter-on-quarter (QoQ) basis.
  • Dishman Carbo reported an operating profit of ₹46.13 crore in Mar 2026, compared with ₹10.44 crore in Dec 2025, representing an increase of 541.86% on a quarter-on-quarter (QoQ) basis.
  • Dishman Carbo reported a profit of ₹21.74 crore in Mar 2026, compared with ₹12.97 crore in Dec 2025, reflecting an increase of 267.62% on a QoQ basis.
  • The earnings per share (EPS) of Dishman Carbo stood at ₹0.21 during Mar 2026.
Know more
Promoters
59.32%
FII
7.45%
Other DII
0.57%
Retail and other
31.60%
Mutual funds
1.06%
Foreign institutions - FII
Compare against other stocks
Dishman Carbo logo
Dishman Carbo
Pharmaceuticals
Add Stock
Add Another

FAQs on Dishman Carbo Share Price